Longeveron Inc LGVN

Healthcare Biotechnology

Longeveron Inc. is a clinical-stage biotechnology company. The Company is focused on developing cellular therapies for specific aging-related and life-threatening conditions. The Company's lead investigational product is the LOMECEL-B cell-based therapy product (Lomecel-B), which is derived from culture-expanded medicinal signaling cells (MSCs) that are sourced from bone marrow of young healthy adult donors. The Company is primarily focused on three pipeline indications, which include Hypoplastic Left Heart Syndrome (HLHS), Alzheimer’s disease (AD) and Aging-related Frailty. Its Lomecel-B has multiple mechanisms of action encompassing pro-vascular, pro-regenerative, anti- inflammatory, and tissue repair and healing effects with potential applications across a spectrum of disease areas. The Company has bone marrow supply contracts in with two suppliers: the Oklahoma Blood Institute and Vista Health Research.

NDAQ:LGVN - Post by User

Longeveron Inc > LGVN ..... has to hold here .... $17.60....

<< Previous

Bullboard Posts

Next >>

Comment by Iseneschalon Nov 23, 2021 1:41pm

19 Views

Post# 34157999

RE:RE:LGVN ..... has to hold here .... $17.60....

Iseneschal wrote:

Iseneschal wrote: If not....I see sub $16 on a hard shake out before the next leg up .... JMHO

Cheers !

Next support at ~ $ 15.30...might go sub $15 ...hard to say

But I would be abuyer there ; )

Cheers !